npj Antimicrobials and Resistance (Sep 2024)

Genomic epidemiology describes introduction and outbreaks of antifungal drug-resistant Candida auris

  • Dana Kappel,
  • Hugh Gifford,
  • Amelie Brackin,
  • Alireza Abdolrasouli,
  • David W. Eyre,
  • Katie Jeffery,
  • Silke Schlenz,
  • David M. Aanensen,
  • Colin S. Brown,
  • Andrew Borman,
  • Elizabeth Johnson,
  • Alison Holmes,
  • Darius Armstrong-James,
  • Matthew C. Fisher,
  • Johanna Rhodes

DOI
https://doi.org/10.1038/s44259-024-00043-6
Journal volume & issue
Vol. 2, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Candida auris is a globally emerged fungal pathogen causing nosocomial invasive infections. Here, we use cutting-edge genomic approaches to elucidate the temporal and geographic epidemiology of drug-resistant C. auris within the UK. We analysed a representative sample of over 200 isolates from multiple UK hospitals to assess the number and timings of C. auris introductions and infer subsequent patterns of inter- and intra-hospital transmission of azole drug-resistant isolates. We identify at least one introduction from Clade I and two from Clade III into the UK, and observe temporal and geographical evidence for multiple transmission events of antifungal drug resistant isolates between hospitals and identified local within-hospital patient-to-patient transmission events. Our study confirms outbreaks of drug-resistant C. auris are linked and that transmission amongst patients occurs, explaining local hospital outbreaks, and demonstrating a need for improved epidemiological surveillance of C. auris to protect patients and healthcare services.